Hydronephrosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 29: Line 29:


==Associated Conditions==
==Associated Conditions==
* Nephrolithiasis
* Nephrolithiasis<ref name="pmid29775451">{{cite journal |vauthors=Wojciechowska M, Bieniaś B, Sobieszczańska-Droździel A, Wieczorkiewicz-Płaza A, Beń-Skowronek I, Sikora P |title=[Recurrent urolithiasis as a symptom of primary hyperparathyroidism in a 16-year-old boy] |language=Polish |journal=Pol. Merkur. Lekarski |volume=44 |issue=262 |pages=208–210 |date=April 2018 |pmid=29775451 |doi= |url=}}</ref>
* Urinary tract infection
* Urinary tract infection
*Congenital malformation
*Congenital malformation

Revision as of 19:05, 23 July 2018

https://https://www.youtube.com/watch?v=mi7XtyHwVHk%7C350}}

Hydronephrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hydronephrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hydronephrosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hydronephrosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hydronephrosis pathophysiology

CDC on Hydronephrosis pathophysiology

Hydronephrosis pathophysiology in the news

Blogs on Hydronephrosis pathophysiology

Directions to Hospitals Treating Hydronephrosis

Risk calculators and risk factors for Hydronephrosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

Hydronephrosis can result from anatomic or functional processes interrupting the flow of urine. This interruption can occur anywhere along the urinary tract from the kidneys to the urethral meatus. The rise in ureteral pressure leads to marked changes in glomerular filtration, tubular function, and renal blood flow. The glomerular filtration rate (GFR) declines significantly within hours following acute obstruction. This significant decline of GFR can persist for weeks after relief of obstruction. In addition, renal tubular ability to transport sodium, potassium, and protons and concentrate and to dilute the urine is severely impaired.

Pathophysiology

  • The obstruction may arise from either inside or outside the urinary tract or may come from the wall of the urinary tract itself.
  • Intrinsic obstructions (those that occur within the tract) include blood clots, stones, sloughed papilla along with tumours of the kidney, ureter and bladder. Extrinsic obstructions (those that are caused by factors outside of the urinary tract) include pelvic or abdominal tumours or masses, retroperitoneal fibrosis or neurological deficits.
  • Strictures of the ureters (congenital or acquired), neuromuscular dysfunctions or schistosomiasis are other causes which originate from the wall of the urinary tract.[1][2]

Genetics

Associated Conditions

  • Nephrolithiasis[6]
  • Urinary tract infection
  • Congenital malformation
  • Tumor
  • Pregnancy
  • Scarring of tissues( From injury or previous surgery)

Gross Pathology

  • On gross pathology, the following features may be see in hydronephrosis.
    • Renal papillary compression

Microscopic Pathology

  • On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

References

  1. Krajewski W, Wojciechowska J, Dembowski J, Zdrojowy R, Szydełko T (August 2017). "Hydronephrosis in the course of ureteropelvic junction obstruction: An underestimated problem? Current opinions on the pathogenesis, diagnosis and treatment". Adv Clin Exp Med. 26 (5): 857–864. PMID 29068584.
  2. Vercellini P, Buggio L, Somigliana E (December 2017). "Role of medical therapy in the management of deep rectovaginal endometriosis". Fertil. Steril. 108 (6): 913–930. doi:10.1016/j.fertnstert.2017.08.038. PMID 29202965.
  3. Izquierdo L, Porteous M, Paramo PG, Connor JM (July 1992). "Evidence for genetic heterogeneity in hereditary hydronephrosis caused by pelvi-ureteric junction obstruction, with one locus assigned to chromosome 6p". Hum. Genet. 89 (5): 557–60. PMID 1634233.
  4. Fryns JP, Kleczkowska A, Moerman P, Vandenberghe K (June 1993). "Hereditary hydronephrosis and the short arm of chromosome 6". Hum. Genet. 91 (5): 514–5. PMID 8357406.
  5. Neas KR, Chia N, Clarke M, Peters G, Adès LC (July 2003). "A case of partial trisomy 4p syndrome presenting as severe hydronephrosis in utero". Clin. Dysmorphol. 12 (3): 179–81. doi:10.1097/01.mcd.0000072162.33788.8d. PMID 14564156.
  6. Wojciechowska M, Bieniaś B, Sobieszczańska-Droździel A, Wieczorkiewicz-Płaza A, Beń-Skowronek I, Sikora P (April 2018). "[Recurrent urolithiasis as a symptom of primary hyperparathyroidism in a 16-year-old boy]". Pol. Merkur. Lekarski (in Polish). 44 (262): 208–210. PMID 29775451.

Template:WH Template:WS